ALT5 Sigma Corporation Appoints Dr. Adel Elmessiry to Board of Directors

Appointment strengthens ALT5's Board with expertise across AI infrastructure, decentralized systems, and global technology governance LAS VEGAS, NEVADA / ACCESS Newswire / February 12, 2026 / ALT 5 Sigma Corporation (the "Company" or "ALT5") (NASDAQ:ALTS)(FRA:5AR1), a fintech company operating institutional-grade global payments, trading, and settlement infrastructure, today announced the appointment of Dr. Adel Elmessiry, Ph.D., as an independent member of its Board of Directors. ...